Company
United StatesPublic company, NASDAQ: LINLinde Inc (NASDAQ: LIN), Muskegon, MI – FDA Inspections
Inspection records and compliance data for Linde Inc in Muskegon, Michigan. 2 FDA inspections on record, last inspected February 23, 2015. Publicly traded as NASDAQ: LIN.
Company Profile
This profile covers Linde Inc based in Muskegon, Michigan, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected February 8, 2012. Last inspected February 23, 2015.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 23, 2015 | NAI | Human Drugs · Drug Quality Assurance | 916771 |
| February 8, 2012 | NAI | Human Drugs · Drug Quality Assurance | 766923 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Linde Inc
Stock ticker
LIN
Exchange
NASDAQ
Share price
$521.47
Market cap
$239.4B
Price as of
November 6, 2026
FEI Number
1814744
Address
363 Ottawa St, Muskegon, Michigan 49442, United States
Country
United States
ID: c1d17044-578d-4391-9fbf-2187ea1115c2